Polly A. Murphy

AVIR

Polly A. Murphy serves as Director at Atea Pharmaceuticals, Inc. (AVIR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$151.2K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$151.2K

Companies Traded

CELC, AVIR

Active Period

Dec 2021 – Nov 2022

2 total trades

Most Recent

Buy CELC

Nov 22, 2022 · $48.4K

Polly A. Murphy's Insider Trading at Atea Pharmaceuticals, Inc. (AVIR)

Buys

1 · $102.8K

Sells

0 · $0.00

Total Shares Bought

12,000

Total Shares Sold

AVIR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 20, 2021↗	Buy	12,000	$8.57	$102.8K	0

Polly A. Murphy's Insider Trading at Celcuity Inc. (CELC)

Buys

1 · $48.4K

Sells

0 · $0.00

Total Shares Bought

5,000

Total Shares Sold

CELC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 22, 2022↗	Buy	5,000	$9.68	$48.4K	0

Related Insiders

John Vavricka

Chief Commercial Officer

AVIRSell · Jan 31, 2026

Andrea Corcoran

See Remarks

AVIRSell · Jan 31, 2026

Wayne Foster

EVP, Chief Accounting Officer

AVIRSell · Jan 31, 2026

Janet MJ Hammond

Chief Development Officer

AVIRSell · Jan 31, 2026

Maria Arantxa Horga

Chief Medical Officer

AVIRSell · Jan 31, 2026

Jean-Pierre Sommadossi

President, CEO, and Chairman

AVIRSell · Jan 31, 2026

David Dalvey

director

CELCSell · Jan 27, 2026

David Dalvey

Director

CELCSell · Jan 27, 2026

Explore More Insider Trading Data

AVIR Insider Trading Activity

View all insider trades at Atea Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity